Mouse GM-CSF FlowCytomix Simplex

Description: This FlowCytomix Simplex Kit is designed for the measurement of Mouse GM-CSF in an immunoassay analyzed on a flow cytometer. Together with the FlowCytomix Mouse Basic Kit (cat. BMS8440FF), this kit can be used to detect GM-CSF alone or can be multiplexed with other Simplex Kits to measure a variety of analytes.

This kit contains bead population B8.

Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a cytokine that has been characterized as a molecule capable of stimulating proliferation and differentiation of granulocyte/macrophage progenitor cells as well as modulating the functional activity of mature granulocytes and macrophages. In combination with erythropoietin, it supports the development of erythroid progenitors in vitro. The biological activities of GM-CSF substantially overlap with the effects of Interleukin 3. The reason for the redundancy of these pleiotropic cytokines may at least in part be explained by their competition for binding to common receptors.
GM-CSF is produced by a number of different cell types such as activated T-cells, B-cells, macrophages, mast cells, endothelial cells, fibroblasts, synoviocytes and various tumor cells in response to various stimuli.
Mouse GM-CSF as well as its receptors have been cloned. The encoded glycoprotein consists of 141 amino acid residues and has a molecular weight of about 23 kDa. The murine protein binds to a high affinity receptor complex consisting of two membrane glycoproteins, the GM-CSF receptor alpha subunit with notable homology to the human receptor and the beta subunit which also forms part of the receptors for IL-3 and IL-5.
Elevated levels of GM-CSF are found in mice after endotoxin injection.

Citations: Wirtz,Stefan; Tubbe,Ingrid; Galle,Peter R.; Schild,Hans J.; Birkenbach,Mark; Blumberg,Richard S.; Neurath,Markus F.. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. Journal of Experimental Medicine 2006;203:1875-1881. (Link)

Romano M,D'Souza S,Adnet PY,Laali R,Jurion F,Palfliet K,Huygen K.. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.. Vaccine 2006;24:4640-4643. (Link)

O'Connor,Richard A.; Prendergast,Catriona T.; Sabatos,Catherine A.; Lau,Clement W.Z.; Leech,Melanie D.; Wraith,David C.; Anderton,Stephen M.. Cutting Edge: Th1 Cells Facilitate the Entry of Th17 Cells to the Central Nervous System during Experimental Autoimmune Encephalomyelitis. The Journal of Immunology 2008;181:3750-3754. (Link)

Raveney,Ben J.E.; Richards,Claire; Aknin,Marie Laure; Copland,David A.; Burton,Bronwen R.; Kerr,Emma; Nicholson,Lindsay B.; Williams,Neil A.; Dick,Andrew D.. The B Subunit of Escherichia coli Heat-Labile Enterotoxin Inhibits Th1 but Not Th17 Cell Responses in Established Experimental Autoimmune Uveoretinitis. Investigative Ophthalmology & Visual Science 2008;49:4008-4017. (Link)

Cuesta,Angel M.; Suarez,Eduardo; Larsen,Martin; Jensen,Kim Bak; Sanz,Laura; Compte,Marta; Kristensen,Peter; varez-Vallina,Luis. Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I. Immunology 2006;117:502-506. (Link)

Brignole,C.; Marimpietri,D.; Pastorino,F.; Di,Paolo D.; Pagnan,G.; Loi,M.; Piccardi,F.; Cilli,M.; Tradori-Cappai,A.; Arrigoni,G.; Pistoia,V.; Ponzoni,M.. Anti-IL-10R antibody improves the therapeutic efficacy of targeted liposomal oligonucleotides. J Control Release 2009;(Link)

Weigmann,Benno; Lehr,Hans A.; Yancopoulos,George; Valenzuela,David; Murphy,Andrew; Stevens,Sean; Schmidt,Jan; Galle,Peter R.; Rose-John,Stefan; Neurath,Markus F.. The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis. Journal of Experimental Medicine 2008;205:2099-2110. (Link)

Leppkes,Moritz; Becker,Christoph; Ivanov,Ivaylo I.; Hirth,Sebastian; Wirtz,Stefan; Neufert,Clemens; Pouly,Sandrine; Murphy,Andrew J.; Valenzuela,David M.; Yancopoulos,George D.; Becher,Burkhard; Littman,Dan R.; Neurath,Markus F.. RORgamma expressing Th17 cells drive chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 2009;136:257-267. (Link)

Thomas,Ian J.; Petrich de Marquesini,Liliana G.; Ravanan,Rommel; Smith,Richard M.; Guerder,Sylvie; Flavell,Richard A.; Wraith,David C.; Wen,Li; Wong,F.Susan. CD86 Has Sustained Costimulatory Effects on CD8 T Cells. The Journal of Immunology 2007;179:5936-5946. (Link)

Ataman-™nal,Y.; Munier,S.; Ganee,A.; Terrat,C.; Durand,P.Y.; Battail,N.; Martinon,F.; Le,Grand R.; Charles,M.H.; Delair,T.; Verrier,B.. Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models. J Control Release 2006;112:175-185. (Link)

Ganta,Roman R.; Cheng,Chuanmin; Miller,Elizabeth C.; McGuire,Bridget L.; Peddireddi,Lalitha; Sirigireddy,Kamesh R.; Chapes,Stephen K.. Differential Clearance and Immune Responses to Tick Cell vs. Macrophage Culture-Derived Ehrlichia chaffeensis in Mice. Infection and Immunity 2006;75:135-145. (Link)

Timmers,Leo; van Keulen,J.Karlijn; Hoefer,Imo E.; Meijs,Matthijs F.L.; van Middelaar,Ben; den Ouden,Krista; van Echteld,Cees J.A.; Pasterkamp,Gerard; de Kleijn,Dominique P.V.. Targeted Deletion of Nuclear Factor {kappa}B p50 Enhances Cardiac Remodeling and Dysfunction Following Myocardial Infarction. Circulation Research 2009;104:699-706. (Link)

Binder,Nikolaus; Niederreiter,Birgit; Hoffmann,Oskar; Stange,Richard; Pap,Thomas; Stulnig,Thomas; Mack,Matthias; Erben,Reinhold; Smolen,Josef; Redlich,Kurt. Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis. Nat Med 2009;15:417-424. (Link)

Timmers L,Sluijter JP,van Keulen JK,Hoefer IE,Nederhoff MG,Goumans MJ,Doevendans PA,van Echteld CJ,Joles JA,Quax PH,Piek JJ,Pasterkamp G,de Kleijn DP.. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res. 2008;102:257-264. (Link)

Liu,Qi; Cheng,Lily I.; Yi,Liang; Zhu,Nannan; Wood,Adam; Changpriroa,Cattlena May; Ward,Jerrold M.; Jackson,Sharon H.. p47phox Deficiency Induces Macrophage Dysfunction Resulting in Progressive Crystalline Macrophage Pneumonia. American Journal of Pathology 2009;174:153-163. (Link)

Loser,Karin; Apelt,Jenny; Voskort,Maik; Mohaupt,Mariette; Balkow,Sandra; Schwarz,Thomas; Grabbe,Stephan; Beissert,Stefan. IL-10 Controls Ultraviolet-Induced Carcinogenesis in Mice. The Journal of Immunology 2007;179:365-371. (Link)

Hildner,K.M.; Schirmacher,P.; Atreya,I.; Dittmayer,M.; Bartsch,B.; Galle,P.R.; Wirtz,S.; Neurath,M.F.. Targeting of the transcription factor STAT4 by antisense phosphorothioate oligonucleotides suppresses collagen-induced arthritis. J Immunol 2007;178:3427-3436. (Link)

Fletcher,Julie M.; Jordan,Margaret A.; Snelgrove,Sarah L.; Slattery,Robyn M.; Dufour,Francois D.; Kyparissoudis,Konstantinos; Besra,Gurdyal S.; Godfrey,Dale I.; Baxter,Alan G.. Congenic Analysis of the NKT Cell Control Gene Nkt2 Implicates the Peroxisomal Protein Pxmp4. The Journal of Immunology 2008;181:3400-3412. (Link)

Pozdzik,A.A.; Salmon,I.J.; Husson,C.P.; Decaestecker,C.; Rogier,E.; Bourgeade,M.F.; schodt-Lanckman,M.M.; Vanherweghem,J.L.; Nortier,J.L.. Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy. Nephrol.Dial.Transplant 2008;23:2480-2491. (Link)

Presser,Katrin; Schwinge,Dorothee; Wegmann,Michael; Huber,Samuel; Schmitt,Steffen; Quaas,Alexander; Maxeiner,Joachim H.; Finotto,Susetta; Lohse,Ansgar W.; Blessing,Manfred; Schramm,Christoph. Coexpression of TGF-{beta}1 and IL-10 Enables Regulatory T Cells to Completely Suppress Airway Hyperreactivity. The Journal of Immunology 2008;181:7751-7758. (Link)

Mrabet-Dahbi,S.; Metz,M.; Dudeck,A.; Zuberbier,T.; Maurer,M.. Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp.Dermatol. 2009;18:437-444. (Link)

Claudio,Estefania; Sonder,Soren Ulrik; Saret,Sun; Carvalho,Gabrielle; Ramalingam,Thirumalai R.; Wynn,Thomas A.; Chariot,Alain; Garcia-Perganeda,Antonio; Leonardi,Antonio; Paun,Andrea; Chen,Amy; Ren,Nina Y.; Wang,Hongshan; Siebenlist,Ulrich. The Adaptor Protein CIKS/Act1 Is Essential for IL-25-Mediated Allergic Airway Inflammation. The Journal of Immunology 2009;182:1617-1630. (Link)

Weigmann,Benno; Lehr,Hans A.; Yancopoulos,George; Valenzuela,David; Murphy,Andrew; Stevens,Sean; Schmidt,Jan; Galle,Peter R.; Rose-John,Stefan; Neurath,Markus F.. The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis. Journal of Experimental Medicine 2008;205:2099-2110. (Link)

References: Bolwell,B.J.. The use of G-CSF and GM-CSF in bone marrow transplantation. Cleve.Clin.J.Med. 1993;60:291-302. (Link)

Groves,R.W.; Schmidt-Lucke,J.A.. Recombinant human GM-CSF in the treatment of poorly healing wounds. Adv.Skin Wound.Care 2000;13:107-112. (Link)

Toren,A.; Nagler,A.. The implications of granulocyte-monocyte colony-stimulating factor (GM-CSF) in cytotoxicity of bone marrow transplantation. Cytokines Cell Mol.Ther. 1998;4:199-206. (Link)

Burgess,A.W.; Metcalf,D.. The nature and action of granulocyte-macrophage colony stimulating factors. Blood 1980;56:947-958. (Link)

Ross,S.D.; DiGeorge,A.; Connelly,J.E.; Whiting,G.W.; McDonnell,N.. Safety of GM-CSF in patients with AIDS: a review of the literature. Pharmacotherapy 1998;18:1290-1297. (Link)

Lim,M.; Simons,J.W.. Emerging concepts in GM-CSF gene-transduced tumor vaccines for human prostate cancer. Curr.Opin.Mol Ther. 1999;1:64-71. (Link)

Drings,P.; Fischer,J.R.. Biology and clinical use of GM-CSF in lung cancer. Lung 1990;168 Suppl:1059-1068. (Link)

Freund,M.; Kleine,H.D.. The role of GM-CSF in infection. Infection 1992;20 Suppl 2:S84-S92. (Link)

Lowenberg,B.; de Greef,G.E.; Wielenga,J.J.. Granulocyte-macrophage colony stimulating factor (GM-CSF) in the treatment of hematological malignancies. Anticancer Drugs 1993;4 Suppl 1:17-20. (Link)

Jones,T.C.. Use of granulocyte-macrophage colony stimulating factor (GM-CSF) in prevention and treatment of fungal infections. Eur.J.Cancer 1999;35 Suppl 3:S8-10. (Link)

Griffin,J.D.; Cannistra,S.A.; Sullivan,R.; Demetri,G.D.; Ernst,T.J.; Kanakura,Y.. The biology of GM-CSF: regulation of production and interaction with its receptor. Int.J.Cell Cloning 1990;8 Suppl 1:35-44. (Link)

Harmenberg,J.; Hoglund,M.; Hellstrom-Lindberg,E.. G- and GM-CSF in oncology and oncological haematology. Eur.J.Haematol.Suppl 1994;55:1-28. (Link)

Hejna,M.; Brodowicz,T.; Zielinski,C.C.. Local use of GM-CSF for severe mucositis. Eur.J.Cancer 1999;35 Suppl 3:S14-S17. (Link)

Harousseau,J.L.; Wu,D.. The use of GM-CSF and G-CSF in the treatment of acute leukemias. Leuk.Lymphoma 1995;18:405-412. (Link)

Hoshi,S.; Yoshizawa,A.; Arioka,H.; Kobayashi,N.; Kudo,K.; Niino,H.. [Anaplastic thyroid carcinoma with lung metastasis producing CA 19-9 and GM-CSF]. Nihon Kokyuki.Gakkai Zasshi 2000;38:391-397. (Link)